Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 03/26 04:14:59 pm
117.6 USD   -0.88%
03/25 VERTEX PHARMACE : Biotech Equities Technical Coverage - ZIOPHARM Onc..
03/23 NASDAQ 100 MOVE : Vrtx, vip
03/23 S&P 500 MOVERS : Vrtx, gnw
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/20/2015 03/23/2015 03/24/2015 03/25/2015 03/26/2015 Date
131(c) 125.79(c) 124.335(c) 118.64(c) 117.6(c) Last
5 731 415 5 118 515 1 780 271 2 429 906 1 902 885 Volume
-2.42% -3.98% -1.16% -4.58% -0.88% Change
More quotes
Financials ($)
Sales 2015 1 086 M
EBIT 2015 -284 M
Net income 2015 -408 M
Finance 2015 570 M
Yield 2015 -
Sales 2016 2 879 M
EBIT 2016 1 239 M
Net income 2016 1 023 M
Finance 2016 1 790 M
Yield 2016 -
PER 2015 -
PER 2016 32,22
EV / Sales 2015 25,7x
EV / Sales 2016 9,27x
Capitalization 28 470 M
More Financials
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
05/05Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
03/26 VERTEX PHARMACEUTICALS : Assigned Patent
03/26 VERTEX PHARMACEUTICALS : Reports Data from 12-Week Phase 2 Safety Study of VX-66..
03/25 CHRISTOPHER WRIGHT : Pronutria Biosciences™ Appoints Dr. Christopher Wrigh..
03/25 VERTEX PHARMACEUTICALS : Patent Issued for Systems and Methods for Inline Sampli..
03/25 VERTEX PHARMACEUTICALS : Receives U.S. Food and Drug Administration Approval of ..
03/25 VERTEX PHARMACEUTICALS : Biotech Equities Technical Coverage - ZIOPHARM Oncology..
03/23 S&P 500 MOVERS : Vrtx, gnw
03/23 NASDAQ 100 MOVERS : Vrtx, vip
More news
Sector news : Biopharmaceuticals
02:35a SHIRE : *repeat: ubs raises shire price target to 6600 pence - 'buy'
02:32a OTSUKA : Announces Change in Status of Representative Director (125KB)
01:36a SHIRE : Acquires Amphetamine Amino Acid Conjugate Products from KemPharm
More sector news : Biopharmaceuticals
News from SeekingAlpha
03/23 2015 could be the year of the blockbuster drug
03/23 Vertex Pharma off on trial data for VX-661
03/18 FDA clears Vertex CF drug for use in younger children
03/16 PDUFA date approaches for Kalydeco label expansion
03/13 NEXT WEEK IN BIOTECH : Vertex PDUFA, Organon Ad Comm


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF